Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | How chronic inflammation contributes to MDS pathophysiology

Rashmi Kanagal-Shamanna • 28 Sep 2022
SOHO 2022
Myelodysplastic Syndromes

Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into the role of chronic inflammation in the pathophysiology of myelodysplastic syndromes (MDS), and further highlights how various mutations and the bone marrow microenvironment contribute to the development of MDS. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Rashmi Kanagal-Shamanna

1:17
Common germline mutations in myelodysplastic syndromes
Rashmi Kanagal-Shamanna • 7 Jun 2023
1:23
Looking forward to the Cancer Genomics Consortium Annual Meeting
Rashmi Kanagal-Shamanna • 7 Jun 2023
4:06
Incidence of germline mutations in patients with myeloid neoplasms with antecedent solid tumors
Rashmi Kanagal-Shamanna • 7 Jun 2023
1:29
Automated tool for MDS classification using the WHO & ICC classification systems
Rashmi Kanagal-Shamanna • 5 May 2023

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:19
Key clinical trials in MDS taking place in the US
Guillermo Garcia-Manero • 9 Apr 2024
1:34
Sequencing of agents in LR-MDS
Guillermo Garcia-Manero • 9 Apr 2024
1:21
HMAs for MDS- a party of one
Guillermo Garcia-Manero • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals